SeedRound Media
Rushed for time? Here is the top 5 Early Stage Venture investors for Finance startups. Scroll down for more information on these investors or to view the rest of the investors.
Name | Website | Stages | Location | Socials |
|---|---|---|---|---|
General Catalyst | Early Stage Venture, Late Stage Venture, Seed | Cambridge, Massachusetts, United States, North America | ||
F-Prime Capital | Early Stage Venture, Late Stage Venture, Seed | Cambridge, Massachusetts, United States, North America | ||
Accomplice | Early Stage Venture, Seed | Cambridge, Massachusetts, United States, North America | ||
Amadeus Capital Partners | Early Stage Venture, Late Stage Venture, Private Equity, Seed | Cambridge, Cambridgeshire, United Kingdom, Europe | ||
Flagship Pioneering | Debt, Early Stage Venture, Late Stage Venture, Private Equity | Cambridge, Massachusetts, United States, North America |
At SeedRound we track over 200,000 investors and over 1,000,000 people who hold key positions in these firms. We use this directory of investors to highlight top employees, LP’s and funding organisations we think deserve more appreciation than they are currently getting.
We’ve ranked the top Finance Early Stage Venture investors in Cambridge. The companies, startups and institutions listed in this article are all exceptional companies, well worth a follow. We have included links to their websites, socials and CrunchBase (if you’re interested in their financials).
We selected the organisations listed in this article based on:
- Track record
- Executive leadership
- Market share
- Innovation
- ESG rating
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Top Finance Investors & Funds (Cambridge)
General Catalyst
General Catalyst is a venture capital firm that provides early-stage and growth equity investments. They provide ongoing momentum that accelerates ideas, careers, and companies toward standout success. They create the ideal conditions for growth, surround clients with the right people, and offer mentorship based on deep experience. To date, General Catalyst has managed eight venture capital funds totaling approximately $3.75 billion in capital commitments.
Stages: Early Stage Venture, Late Stage Venture, Seed
Location: Cambridge, Massachusetts, United States, North America
Industries: Asset Management, Finance, Financial Services, Venture Capital
Follow:
F-Prime Capital
F-Prime’s roots are in one of America’s great entrepreneurial success stories. Fidelity Investments was founded in 1946 and grew from a single mutual fund into one of the largest asset management firms in the world, with over $2 trillion in assets under management. For the last forty years, this venture capital group has had the privilege of backing other great entrepreneurs as they built ground-breaking companies in technology and life sciences, including Atari, MCI, ROLM Corp., Alibaba, Ironwood Pharmaceuticals, and Ultragenyx. Today, F-Prime’s funds are larger and more global, but its teams are still small and local. F-Prime stays true to its entrepreneurial roots. In the US and Europe, F-Prime Capital Partners is investing in healthcare (formerly Fidelity Biosciences) and in technology (formerly part of Devonshire Investors). In other geographies, its sister fund is called Eight Roads (formerly Fidelity Growth Partners), with investment teams in London, Shanghai, Beijing, Hong Kong, Tokyo, and Mumbai. Together F-Prime brings a world of insight, domain expertise and relationships to support entrepreneurs. Without the pressure of fundraising from outside investors, F-Prime Capital Partners focuses all of its time finding and helping great entrepreneurs build important companies.
Stages: Early Stage Venture, Late Stage Venture, Seed
Location: Cambridge, Massachusetts, United States, North America
Industries: Business Development, Finance, Financial Services, Venture Capital
Follow:
Accomplice
Accomplice is a seed-led venture capital firm that invests in technology startup companies. Its specialties are cybersecurity, eSports, data analytics, SMB class software, emerging hardware platforms, and marketplaces. Through platforms like AngelList, Boston Syndicates, and Maiden Lane, Accomplice harnesses the community to empower and fund the best founders. It has pioneered a community approach through platforms like Spearhead, BOSS, Rev, and TUGG. A majority of Accomplice’s investments are in Boston, with others throughout the U.S., Canada, and the E.U. Formerly known as Atlas Venture, the firm announced in October 2014 that it was splitting its technology and life sciences franchises. The technology group was renamed Accomplice; the life sciences group retained the name Atlas Venture. Headquartered in Cambridge, Massachusetts, Accomplice is one of the most active early-stage firms in New England.
Stages: Early Stage Venture, Seed
Location: Cambridge, Massachusetts, United States, North America
Industries: Business Development, Finance, Financial Services, Venture Capital
Follow:
Amadeus Capital Partners
Amadeus Capital is a global technology investor that invests in technology companies at all stages, from seed to venture buyout; they also buy stakes from other investors or founders, to ensure that companies and entrepreneurs have the runway they need to succeed. They invest in a broad variety of sectors including enterprise and infrastructure software, consumer and business services, medical technology and healthcare IT, and cleantech and resource efficiency. It has the imagination to see where new businesses can be created and the technical insight, operational experience and global network to help entrepreneurs make their vision a reality. The Company was founded in 1997 and since has backed more than 130 companies and raised over $1bn for investment.
Stages: Early Stage Venture, Late Stage Venture, Private Equity, Seed
Location: Cambridge, Cambridgeshire, United Kingdom, Europe
Industries: Finance, Financial Services, Venture Capital
Follow:
Flagship Pioneering
Flagship Pioneering conceives, creates, resources, and grows first-in-category ventures to transform human health and sustainability. They accelerate Flagship Pioneering’s advances in biology, engineering, medicine, energy, and beyond. The firm harnesses science and entrepreneurialism to envision alternative futures, beginning with seemingly unreasonable propositions and navigating to transformational outcomes through an evolutionary methodology. Flagship Pioneering combines innovative capacity, entrepreneurial leadership, and professional capital management in a single enterprise that systematically produces first-in-category companies. They attract, develop, and retain the top scientific, entrepreneurial, and managerial talent in the world.
Stages: Debt, Early Stage Venture, Late Stage Venture, Private Equity
Location: Cambridge, Massachusetts, United States, North America
Industries: Biotechnology, Business Development, Finance, Health Care, Venture Capital
Follow:
HealthCare Ventures
HealthCare Ventures is a leading life science venture capital firm investing in pre-clinical or early clinical stage, focused companies with potential to transform patient care.
Stages: Debt, Early Stage Venture, Late Stage Venture, Private Equity
Location: Cambridge, Massachusetts, United States, North America
Industries: Finance, Financial Services, Venture Capital
Follow:
Cambridge Innovation Capital
Cambridge Innovation Capital backs world-leading life sciences and technology companies with an affiliation to Cambridge, Europe’s leading capital for innovation. As a preferred investor for the University of Cambridge, we have unparalleled access to investment opportunities in the ecosystem. Since our inception in 2013, we have raised £275 million to invest in disruptive, deep-tech businesses in sectors including, but not limited to, artificial intelligence, internet of things, quantum technologies, autonomous systems, therapeutics, medtech/diagnostics, digital health and genomics/proteomics.
Stages: Early Stage Venture, Seed
Location: Cambridge, Cambridgeshire, United Kingdom, Europe
Industries: Finance, Financial Services, Intellectual Property, Venture Capital
Follow:
Fairhaven Capital Partners
Fairhaven Capital Partners (previously [TD Capital](http://www.crunchbase.com/financial-organization/td-capital)) is a Cambridge, Massachusetts based venture capital firm investing in early stage, high potential companies with rapid growth characteristics.
Stages: Early Stage Venture, Late Stage Venture, Seed
Location: Cambridge, Massachusetts, United States, North America
Industries: Finance, Financial Services, Venture Capital
Follow:
Cambridge Capital Group
Cambridge Capital Group (CCG) is a leading business angel group of 70+ investors who have been investing in hi-tech businesses for more than a decade. CCG was formed in the Autumn of 2000 and has been backing tech start-ups in the region ever since. Their members have invested several millions of pounds into more than 30 live portfolio companies in the Cambridge technology cluster. Membership is an application process, normally following introductions by existing members. Their partner networks are Anglia Capital Group and CCG International, both of which benefit from deal flow developed in Cambridge, Europe’s leading hi-tech cluster.
Stages: Early Stage Venture, Late Stage Venture, Seed
Location: Cambridge, Cambridgeshire, United Kingdom, Europe
Industries: Angel Investment, Finance, Financial Services
Follow:
Martlet Capital
Martlet Capital is an early-stage investor based in Cambridge, providing patient capital to deep technology and life science startups with high growth potential. They seek to support entrepreneurs with value beyond capital. They have experience of helping companies scale from first-round through to exit. Visit their website to take a look at how we work and their investment focus.
Stages: Early Stage Venture, Seed
Location: Cambridge, Cambridgeshire, United Kingdom, Europe
Industries: Angel Investment, Finance, Financial Services
Follow:
SpringTide Ventures
SpringTide is a venture capital that provides investment in the health tech industry. The firm was founded in 2018 and is headquartered in Cambridge, Massachusetts, United States.
Stages: Early Stage Venture, Late Stage Venture
Location: Cambridge, Massachusetts, United States, North America
Industries: Finance, Financial Services, FinTech, Health Care
Follow:
TTP Ventures
TTP Ventures provides venture capital for IT and clean technology companies based in the UK. It is currently managing a £34m first fund
Stages: Early Stage Venture, Late Stage Venture
Location: Melbourn, Cambridgeshire, United Kingdom, Europe
Industries: Finance, Financial Services, Venture Capital
Follow:
Action Potential Venture Capital
GlaxoSmithKline today announced the launch of Action Potential Venture Capital (APVC) Limited, a new $50 million strategic venture capital fund that will invest in companies that pioneer bioelectronic medicines and technologies. The fund’s first investment will be in SetPoint Medical, a California company considered a trailblazer in creating implantable devices to treat inflammatory diseases. The fund complements the work of GSK’s Bioelectronics R&D unit, which was established in 2012 after a two-year effort to seek out and engage the most promising researchers in this emerging area of science. The name of the fund comes from electrical signals called action potentials that pass along the nerves in the body. Irregular or altered patterns of these impulses may occur in association with a broad range of diseases. GSK believes that miniaturised devices, or bioelectronic medicines, can be designed to read these patterns. The devices could be designed to interface between the peripheral nervous system and specific organs to read, change or generate electronic impulses that help treat disorders as diverse as inflammatory bowel disease or rheumatoid arthritis; respiratory diseases such as asthma and COPD and metabolic diseases including Type 2 diabetes. The field of bioelectronic medicines is in its very early stages. GSK’s ambition, through collaboration with scientists globally, is to have the first medicine that speaks the electrical language of our body ready for approval by the end of this decade.“We want to help create the medicines of the future and be the catalyst for this work,” said Moncef Slaoui, chairman of R&D and architect of GSK’s early stage investment strategy. “GSK can play the integrating role that is needed to drive this new type of medical treatment all the way from the bench to the patient and this fund is a key part of our efforts.” Action Potential Venture Capital intends to build a portfolio of five to seven companies over the next five years. The fund will focus investments in three areas: – New start-up companies that aim to pursue the vision of bioelectronic medicines – Existing companies with technologies that are interacting with the peripheral nervous system through first-generation devices that can stimulate or block electrical impulses – Companies advancing technology platforms that will underpin these treatment modalities Action Potential Venture Capital will be based in Cambridge, Massachusetts and managed by a small, dedicated team. The fund has named Imran Eba as its first partner. Imran will move from GSK’s Worldwide Business Development organisation and work closely with the Bioelectronics R&D unit.
Stages: Early Stage Venture
Location: Cambridge, Massachusetts, United States, North America
Industries: Finance, Venture Capital
Follow:
Avlar BioVentures
Avlar was founded in 1999 by Alan Goodman and Daniel Roach and manages Avlar Fund II (£43m) and the First Cambridge Gateway Fund (£35m). Avlar has invested in eighteen companies across a range of sub-sectors of the bioscience industries. Ten are still private, two have been merged, three have been bought by public companies, two have been sold for cash and two listed on the public markets. Prior to the formation of Avlar Messrs Roach and Goodman co-founded or seed financed nine life science companies. Seven of these were listed on recognized Stock Exchanges producing highly profitable realizations. These included Acambis, Chiroscience, Core, Salix and Oxford Biomedica.
Stages: Early Stage Venture, Late Stage Venture
Location: Madingley, Cambridgeshire, United Kingdom, Europe
Industries: Finance, Financial Services, Venture Capital
Follow:
YankeeTek Ventures
YankeeTek Ventures founded in early 2000, is a venture capital fund for early-stage technology companies. YankeeTek helps entrepreneurs launch their start-ups by providing comprehensive resources, strategic advice, and an extensive network of business relationships to rapidly grow their ideas into strong, successful companies. Fund investors include 3Com, Compaq, Nortel Networks, Novell and The Yankee Group. Several venture capital funds are also invested in YankeeTek, including Advanced Technology Ventures, Advent International, Bain Capital, Battery Ventures, Boston Millennia Partners, HarbourVest Partners, and TH Lee Putnam Ventures.
Stages: Early Stage Venture
Location: Cambridge, Massachusetts, United States, North America
Industries: Finance
Follow:
Suffolk Equity Partners
Suffolk Equity Partners was founded in 2011 as an investment vehicle focused on finding businesses and entrepreneurs of promise. We seek companies and people we believe in, and help them achieve their goals of growth and improvement. With experience in finance, distribution, retail, operational management, and family business, the Suffolk Equity team believes in portfolio diversity and finding thoughtful ways to add value to our portfolio companies.
Stages: Early Stage Venture, Seed
Location: Cambridge, Massachusetts, United States, North America
Industries: Angel Investment, Finance, Venture Capital
Follow:
Brookline Venture Partners
Brookline Venture Partners was founded in 2004 to invest in early-stage companies. Its founders are entrepreneurs with operational, financial, and sales experience. BVP partners Ken Levine and Mark Goodman bring a wealth of experience to their portfolio companies, providing strategic and tactical advice to management teams as they navigate the numerous challenges facing start-up companies.
Stages: Early Stage Venture, Late Stage Venture
Location: Cambridge, Massachusetts, United States, North America
Industries: Finance, Financial Services, Venture Capital
Follow:
Invoke Capital
Invoke Capital Partners was founded by Dr Mike Lynch, members of the senior management team from Autonomy, and a group of technology experts, with access to $1bn in capital. Invoke is focused on maximizing the potential of European fundamental technology by using its unique expertise and repositioning experience to rapidly scale them across multiple markets. It is the only investment team in Europe with a dedicated, in-house R&D division, based in Cambridge, UK. The Invoke team has grown multiple technology businesses with particular expertise and experience in science and technology allowing them to identify and develop core technologies in areas including genomics, security, pattern recognition, signal processing and big data.
Stages: Early Stage Venture
Location: Cambridge, Cambridgeshire, United Kingdom, Europe
Industries: Finance, Financial Services, Venture Capital
Follow:
Acacia Capital Partners
Acacia Capital Partners is an independent management company made up of experienced venture capitalists with in-depth operational and investment management experience. They invest in later stage innovative technology companies both directly and indirectly.
Stages: Early Stage Venture
Location: Cambridge, Cambridgeshire, United Kingdom, Europe
Industries: Finance, Financial Services, Venture Capital
Follow:
Fund Twenty8
Smart Beta for Early stage investing – Fund Twenty8 The fund is the first passive EIS fund for early stage investments. It will deliver a multi-sector and large portfolio for investors. They believe Fund Twenty8 addresses two key areas currently underserved by the EIS fund market. A lack of sector diversification within a fund and a failure to benefit from a wide portfolio approach investing. Traditional early stage funds usually focus on a single sector (exposing investors to sector-specific risks) and usually only invest in 5 to 8 investments per fund. They feel there is a need in the market for a multi-sector and large portfolio fund for early stage investments. That’s why they created Fund Twenty8. Fund Twenty8 offers investors access to a diversified portfolio with at least 28 investments per fund and across multiple sectors.
Stages: Early Stage Venture, Private Equity, Seed
Location: Cambridge, Cambridgeshire, United Kingdom, Europe
Industries: Finance, Financial Services, Venture Capital
Follow:
NW Brown Ventures
NW Brown was founded in Cambridge in 1974 and has grown alongside the city’s thriving economy. In 2009, they purchased a Norwich-based company of financial advisers with a similar philosophy of providing clients with quality service.
Stages: Early Stage Venture
Location: Cambridge, Cambridgeshire, United Kingdom, Europe
Industries: Finance, Financial Services, Venture Capital
Follow:
CREATE Partners
CREATE Partners Ltd, is a fund management company that is focused on providing value beyond capital – to generate profitable returns to shareholders. They pride their selves on their attention to detail, and high levels of integrity learned first hand in the investment banking sector. Since its establishment in 2000, CREATE has built a reputation for successfully implementing an innovative investment approach to meet the needs of investors seeking international diversification in specialist private equity funds.
Stages: Early Stage Venture
Location: Cambridge, Cambridgeshire, United Kingdom, Europe
Industries: Finance, Financial Services
Follow:
